Skip to main content

Table 5 Univariate analysis comparing ICU survivors and non-survivors

From: Prognosis and ICU outcome of systemic vasculitis

n

Deceased (16)

Survived (15)

p

Age, years

69,5 [29–86]

57 [32–78]

0,04

Sex ratio, m/f

12/4

9/6

0,45

BVAS

24.5 [12.0-52.0]

21.0 [2.0-28.0 ]

0,06

SAPS II

46.5 [21.0-109.0]

35.0 [13.0- 51.0]

0,004

Mechanical Ventilation, n (%)

15 (94%)

10 (67%)

0.08

SOFA

7.0 [2.0-15.0]

3.5 [1.0-10.0]

0.006

VAP, n (%)

10 (62.5%)

10 (66.7%)

0.80

Vasopressive agents, n (%)

13 (81,3%)

5 (33,3%)

0.006

ARDS, n (%)

13 (81,3%)

4 (26,7%)

0.002

RRT, n (%)

13 (81,3%)

5 (33,3%)

0.007

Creatininemia, microm/l

297 [56–1067.0]

76 [32–449]

0.062

  1. Data are presented as median (range) or No/total patients.
  2. BVAS Birmingham Vasculitis Activity Score, SAPSII simplified acute physiology score II, SOFA sequential organ failure assessment, VAP ventilator associated pneumonia, ARDS acute respiratory distress syndrome, RRT renal replacement therapy.